Barbie® Introduces First-Ever Barbie Doll with Type 1 Diabetes to Expand Representation and Inspire More Children
'Introducing a Barbie doll with type 1 diabetes marks an important step in our commitment to inclusivity and representation,' said Krista Berger, Senior Vice President of Barbie and Global Head of Dolls. 'Barbie helps shape children's early perceptions of the world, and by reflecting medical conditions like T1D, we ensure more kids can see themselves in the stories they imagine and the dolls they love.'
To ensure the doll design truly captures the community, Barbie partnered with Breakthrough T1D (formerly JDRF), the leading global type 1 diabetes research and advocacy organization committed to accelerating life-changing breakthroughs to cure, prevent, and treat type 1 diabetes and its complications. T1D is a chronic autoimmune condition that causes the pancreas to make very little insulin or none at all, leading to dependence on insulin therapy and the risk of short and or long-term complications. Barbie worked closely with Breakthrough T1D to accurately reflect the medical equipment those with this condition may utilize and the doll's look, all the way down to the dress pattern:
Continuous Glucose Monitor (CGM): The doll wears a CGM on her arm to help manage her type 1 diabetes. CGMs are small, wearable devices that continuously measure a person's blood-sugar levels. To keep her CGM in place, she uses heart-shaped medical tape – Barbie pink, of course – along with a phone that displays a CGM app to help track her blood sugar levels throughout the day.
Insulin Pump: Barbie has an insulin pump, a small, wearable medical device that allows for automated insulin dosing as needed, attached to her waist.
Blue Polka Dot Outfit: The doll wears a stylish polka dot top and matching skirt with ruffles. Both the color blue and circle print are nods to the global symbols that represent diabetes awareness.
Purse: The doll comes with a pastel blue purse, perfect for Barbie to carry any essentials, such as type 1 diabetes supplies or snacks, when she's on the go.
'We were thrilled when Barbie approached us to collaborate on the development of the Barbie doll with type 1 diabetes,' said Aaron J. Kowalski, Ph.D., CEO of Breakthrough T1D. 'I have lived with T1D since I was 13, and my brother since he was 3, so this partnership is deeply personal – it means the world to be part of bringing greater visibility to a condition that affects so many families. It's an honor to work with a brand that shares our commitment to showing children that a life with type 1 diabetes can be full, vibrant, and empowering.'
In continued partnership with Breakthrough T1D, Barbie donated dolls to the Breakthrough T1D 2025 Children's Congress. The biennial event, July 7-9, brings 170 children living with type 1 diabetes, ages 4-17, to Washington, DC, to meet face-to-face with members of Congress. The youth delegates travel to the nation's capital from all 50 states and Breakthrough T1D's international affiliates in the United Kingdom, Australia, Israel, the Netherlands, and Canada.
Barbie also honored two global role models and type 1 diabetes advocates – Peloton Instructor Robin Arzón in the US and model Lila Moss in the UK – with their own one-of-a-kind Barbie dolls. Arzón unveiled the new Barbie doll with type 1 diabetes and her one-of-a-kind Barbie doll at Peloton Studios NY on July 8th. Attendees and Members of the type 1 diabetes community were delighted to experience this first-of-its-kind unveiling moment.
'After being diagnosed with type 1 diabetes a decade ago, I've found a lot of purpose in advocating for people with the condition and educating others about it because knowledge is power – especially for young minds,' said Arzón. 'It's an absolute honor to receive a Barbie doll as a part of the brand's efforts to grow awareness and representation surrounding type 1 diabetes, so that we can help show kids that all types of challenges give us all the more reason to push forward and achieve our dreams.'
Lila Moss says, 'I am proud to use my platform to educate around type 1 diabetes and show that being different is cool. Receiving messages from people who see my patches and feel represented means everything to me. To be able to now see Barbie dolls with T1D, and to receive a Barbie doll that visibly looks like me even wearing her patches, is both surreal and special.'
The Barbie Fashionistas line features more than 175 looks across various skin tones, eye colors, hair colors and textures, body types, disabilities, and fashion styles, including a Blind Barbie doll, a Barbie doll with Down Syndrome, and a Barbie doll with Hearing Aids, among others. In 2020, Barbie kicked off a multi-year study with researchers at Cardiff University on the short-term and long-term benefits of doll play. It has been found that doll play serves an incredible purpose during key developmental stages, as it may help set children on a course for success by fostering empathy and developing social skills needed to excel, all while imagining their futures on an equal playing field.
The 2025 Barbie Fashionistas dolls commit to a minimum of 50% ISCC-Certified bio-circular plastic (Mass Balance Approach), with all boxes made from FSC-certified materials. By incorporating ISCC-certified plastic into these dolls, Barbie aims to reduce reliance on fossil-based materials in support of a more circular economy.
The 2025 Barbie Fashionistas dolls, including the Barbie doll with Type 1 diabetes, are now available on Mattel Shop and at retailers nationwide.
About Mattel
Mattel is a leading global toy and family entertainment company and owner of one of the most iconic brand portfolios in the world. We engage consumers and fans through our franchise brands, including Barbie®, Hot Wheels®, Fisher-Price®, American Girl®, Thomas & Friends™, UNO®, Masters of the Universe®, Matchbox®, Monster High®, MEGA® and Polly Pocket®, as well as other popular properties that we own or license in partnership with global entertainment companies. Our offerings include toys, content, consumer products, digital and live experiences. Our products are sold in collaboration with the world's leading retail and ecommerce companies. Since its founding in 1945, Mattel is proud to be a trusted partner in empowering generations to explore the wonder of childhood and reach their full potential. Visit us at mattel.com
About Breakthrough T1D, Formerly JDRF
As the leading global type 1 diabetes (T1D) research and advocacy organization, Breakthrough T1D (formerly JDRF) helps make everyday life with type 1 diabetes better while driving toward cures. We do this by investing in the most promising research, advocating for progress by working with government to address issues that impact the T1D community, and helping educate and empower individuals facing this condition.
About Type 1 Diabetes (T1D)
T1D is an autoimmune condition that causes the pancreas to make very little insulin or none at all. This leads to dependence on insulin therapy and the risk of short and long-term complications, which can include highs and lows in blood sugar; damage to the kidneys, eyes, nerves, and heart; and even death. Globally, it impacts nearly 9 million people. Many believe T1D is only diagnosed in childhood and adolescence, but diagnosis in adulthood is common and accounts for nearly 50% of all T1D diagnoses. The onset of T1D has nothing to do with diet or lifestyle. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. There is currently no cure for T1D.
MAT-BARB
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
AHF Dedicates Tacoma Healthcare Center and AHF Wellness Center
TACOMA, Wash.--(BUSINESS WIRE)-- AIDS Healthcare Foundation (AHF) is pleased to announce the dedication of its AHF Healthcare Center and Wellness Center in Tacoma, Washington, with a ribbon-cutting ceremony set for Friday, July 11. The state-of-the-art facility, AHF's first in the Tacoma area—features AHF's innovative patient-centered clinic model, eliminating waiting rooms. The health care center delivers cutting-edge medical care and services to patients living with HIV regardless of insurance status or ability to pay. The site also houses an AHF Wellness Center, offering free and confidential STD and HIV testing, counseling, and access to resources like PrEP and PEP. 'Our Tacoma AHF Healthcare and Wellness Centers have no waiting room, so patients are immediately escorted to treatment rooms and serviced from a centrally located provider workstation,' said Marcelino Alcorta, AHF Western Bureau Chief. 'The goal here is to maximize efficiency using this innovative patient-centered model to improve health outcomes and increase retention in care.' AHF Tacoma The AHF Tacoma Healthcare and Wellness Center offers welcoming, client-centered care designed to meet the evolving needs of Pierce County's most vulnerable residents. Core services include: Primary HIV Medical Care & Wellness Services, Medical Case Management & Care Coordination, Free Comprehensive HIV/STI Testing, Same-Day PrEP (Pre-Exposure Prophylaxis) for HIV prevention, and an on-site Wellness Center for walk-in sexual health support. AHF Wellness Centers are a part of AHF's broader mission to provide comprehensive HIV/AIDS prevention, treatment, and advocacy. AHF Tacoma also operates a Mobile Testing Unit that delivers free HIV/STI testing directly into the community—meeting clients where they are and eliminating barriers to access for those most in need. Additional Supportive Services at AHF Tacoma With funding from Washington State's Ryan White Part B program, AHF Tacoma provides wraparound services that address key social determinants of health. These services include: Medical Case Management – individualized treatment coordination, Food Vouchers – addressing nutritional needs, Linguistic Services – inclusive and culturally competent care, Housing Assistance – supporting housing stability for clients, Psychosocial Support – mental health and peer services, and Emergency Financial Assistance – for urgent, short-term needs. These services are particularly critical for clients experiencing compounding vulnerabilities, including LGBTQIA+ individuals facing stigma, housing insecurity, and limited access to affirming healthcare. Washington State HIV and STIs (2023) In 2023, over 39,000 people were newly diagnosed with HIV/AIDS in the United States. In Washington state, 421 people were newly diagnosed (rate of 5.4 per 100,000 population) and for Tacoma city, Pierce County, 60 people were diagnosed (rate of 6.4 per 100,000 population) in that same time period [A]. 14,873 people are living with HIV in Washington state, 12,803 are engaged in care (86%), and 11,711 have achieved viral suppression (79%) [A]. In Pierce County, 1,694 people are living with HIV which is 11% of all people living with HIV in the state. 1,385 are engaged in care (82%), and 1,239 have achieved viral suppression (73%). Pierce is the county with the second highest HIV prevalence and new diagnoses after King County (Seattle) in Washington. AIDS Healthcare Foundation (AHF), the world's largest HIV/AIDS healthcare organization, provides cutting-edge medicine and advocacy to more than 2.4 million individuals across 48 countries, including the U.S. and in Africa, Latin America/Caribbean, the Asia/Pacific Region, and Eastern Europe. In January 2025, AHF received the MLK, Jr. Social Justice Award, The King Center's highest recognition for an organization leading work in the social justice arena. To learn more about AHF, visit us online at find us on Facebook, and follow us on Instagram, Twitter, and TikTok.
Los Angeles Times
an hour ago
- Los Angeles Times
Mattel's newest Barbie has diabetes
Dressed in a matching polka dot tank top and ruffled skirt with blue chunky heeled boots and a mini purse, Mattel's newest Barbie may look like previous dolls at first glance. But this particular doll stands out with a wearable insulin pump on her waist, a glucose monitor on her arm and a phone showing her blood sugar readings, making her the El Segundo-based toy company's first Barbie with Type 1 diabetes. The doll continues Mattel's expansion of representation across its flagship brand. The Barbie Fashionistas line features more than 175 looks across various skin tones, body types and disabilities, including previous additions like a blind Barbie, a Barbie with Down syndrome and a Barbie with hearing aids. The company's commitment to representation has proved commercially successful. In 2024, the top 10 most popular Barbie Fashionista dolls globally included the blind Barbie and the Barbie with Down syndrome. The Fashionistas series also includes dolls with vitiligo, prosthetic limbs and wheelchairs. The wheelchair-using doll has consistently been a top performer since its introduction in 2019. Krista Berger, senior vice president of Barbie and global head of dolls at Mattel, said Barbie helps shape children's early perceptions of the world. Reflecting medical conditions like T1D ensures 'more kids can see themselves in the stories they imagine and the dolls they love.' The doll was developed with Breakthrough T1D, the leading global Type 1 diabetes research and advocacy organization. The partnership ensured medical accuracy while incorporating diabetes awareness symbols through the clothes' blue coloring and polka dot pattern. Aaron J. Kowalski, chief executive of Breakthrough T1D, said the partnership is about 'bringing greater visibility to a condition that affects so many families.' The doll launched Tuesday during Breakthrough T1D's 2025 Children's Congress in Washington, D.C. The event brings together more than 170 children living with Type 1 diabetes, giving them face time with members of Congress to advocate for ongoing funding for Type 1 diabetes research. This year they asked members of Congress to renew funding for the Special Diabetes Program. The Special Diabetes Program's current funding expires after September. The program, first allocated by Congress in 1997, faces uncertainty amid recent cuts to federally-funded projects. Type 1 diabetes is an autoimmune condition affecting nearly 9 million people globally, with about 352,000 children living with diabetes in the United States. The CDC reports that 1.7 million individuals 20 or older live with Type 1 diabetes and use insulin. The new Barbie is available through Mattel Shop and retailers nationwide.
Business Wire
an hour ago
- Business Wire
Feinstein Institutes Explores Noninvasive Bioelectronic Medicine to Manage Insulin, Blood Sugar After Surgery
MANHASSET, N.Y.--(BUSINESS WIRE)--Scientists and engineers at Northwell Health's Feinstein Institutes for Medical Research conduct bioelectronic medicine research to treat disease and injury, and recently found that focused ultrasound (FUS) has potential to manage high blood sugar after surgery. Published recently in Bioelectronic Medicine, an open-access journal distributed by the Feinstein Institutes and BMC, part of Springer Nature, used FUS to target a bundle of nerves – including branches from the vagus nerve – that communicate with organs like the liver and pancreas, essential for regulating glucose levels. The high-frequency sound waves of FUS activate neurons in the abdomen and alter neuronal signals that regulate production of insulin and other hormones. 'Managing disorders associated with high blood sugar, including hyperglycemia after surgery, is a critical challenge and current methods often fall short,' said Stavros Zanos, MD, PhD, professor in the Institute of Bioelectronic Medicine at the Feinstein Institutes and corresponding author of the paper. 'This research explores FUS, a new method for non-invasive neuromodulation, that may offer a potential pathway towards safer and more effective blood sugar control without the use of medications.' Using animal models, researchers targeted a nerve bundle called the superior mesenteric plexus (SMP) with FUS and measured its effects on insulin sensitivity, a key factor in how the body processes sugar. They found that FUS initially improved insulin sensitivity during surgery, however, when they checked the animals' blood sugar the day after, it was unexpectedly higher in the group that received FUS compared to the group that didn't. This suggests that while FUS can have immediate positive effects on insulin sensitivity, it might interfere with the body's natural ability to manage blood sugar in the hours following the stress of surgery. Next steps in this research will optimize the FUS treatment to attain long-lasting and beneficial effects on glucose metabolism after surgery and to better understand the biological mechanisms behind these effects. 'Dr. Zanos use of focused ultrasound is paving the way for new methods to stimulate the vagus nerve,' said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research. 'Since vagus nerve reflexes control blood glucose and insulin levels, I expect these results will generate widespread interest from scientists, physicians, and future patients.' Built on years of research in molecular mechanisms of disease and the link between the nervous and immune systems, researchers at the Feinstein Institutes discovered neural targets that can be activated or inhibited with neuromodulation devices, like vagus nerve implants, to control the body's immune response and inflammation. If inflammation is successfully controlled, diseases – such as arthritis, pulmonary hypertension, Crohn's disease, inflammatory bowel diseases, diabetes, cancer and autoimmune diseases – can be treated more effectively. Beyond inflammation, using novel brain-computer interfaces, Feinstein Institutes researchers developed techniques to bypass injuries of the nervous system so that people living with paralysis can regain sensation and use their limbs. By producing bioelectronic medicine knowledge, disease and injury, could one day be treated with our own nerves without costly and potentially harmful pharmaceuticals. Dr. Zanos, along with Sangeeta S. Chavan, PhD, professor in the Institute of Bioelectronic Medicine at the Feinstein Institutes, also led a successful first-in-human trial using FUS to reduce inflammation, targeting at the spleen in healthy participants and found it lowered levels of an inflammatory protein in the blood for over two hours About the Feinstein Institutes The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50+ research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its six institutes of behavioral science, bioelectronic medicine, cancer, health system science, molecular medicine, and translational research. We are the global scientific leader in bioelectronic medicine – an innovative field of science that has the potential to revolutionize medicine. The Feinstein Institutes publishes two open-access, international peer-reviewed journals Molecular Medicine and Bioelectronic Medicine. Through the Elmezzi Graduate School of Molecular Medicine, we offer an accelerated PhD program. For more information about how we produce knowledge to cure disease, visit and follow us on LinkedIn.
